IMAB - I-Mab - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMAB is currently covered by 1 analysts with an average price target of $9. This is a potential upside of $5.02 (126.13%) from yesterday's end of day stock price of $3.98.

I-Mab's activity chart (see below) currently has 44 price targets and 55 ratings on display. The stock rating distribution of IMAB is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 34.61% with an average time for these price targets to be met of 101.93 days.

Highest price target for IMAB is $9, Lowest price target is $9, average price target is $9.

Most recent stock forecast was given by from BTIG on 24-Oct-2025. First documented stock forecast 11-Feb-2020.

Currently out of the existing stock ratings of IMAB, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Sep-2025

$9

$5.02 (126.13%)

$9

11 months 13 days ago
(24-Oct-2025)

0/3 (0%)

$4.78 (113.27%)

Buy Since 02-Nov-2021

$6

$2.02 (50.75%)

$5

1 years 29 days ago
(08-Sep-2025)

3/7 (42.86%)

$1.73 (40.52%)

40

Buy Since 28-Aug-2025

$8

$4.02 (101.01%)

1 years 1 months 9 days ago
(28-Aug-2025)

0/1 (0%)

$3.75 (88.24%)

Buy Since 09-Jul-2025

$7

$3.02 (75.88%)

$7

1 years 1 months 16 days ago
(21-Aug-2025)

1/5 (20%)

$2.29 (48.62%)

85

Buy Since 07-Dec-2020

$7

$3.02 (75.88%)

$7

1 years 1 months 16 days ago
(21-Aug-2025)

2/8 (25%)

$2.29 (48.62%)

59

Show more analysts

Please expand the browser size to see the chart

What is IMAB (I-Mab) average time for price targets to be met?

On average it took 102 days for the stock forecasts to be reached, with an average price target met ratio of 34.61%.

Which analyst most recently updated their price target on IMAB (I-Mab)?

Which analyst has the most public recommendations on IMAB (I-Mab)?

has 0 price targets and 0 ratings on IMAB

Which analyst is the currently most bullish on IMAB (I-Mab)?

Justin Zelin with the highest potential upside of $5.02

Which analyst is the currently most reserved on IMAB (I-Mab)?

Louise Chen with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?